
You're building fast, talking to investors and trying to raise before anyone can agree on what your company is worth. That is the moment when many founders reach for a Simple Agreement for Future Equity (SAFE), a way to take in capital now and set the price later.
This guide walks through how SAFEs work, the terms you need to watch and the cap table consequences that arise when your priced round arrives.
A SAFE is a contract in which an investor wires you money now in exchange for the right to equity in the future. No shares change hands at signing. The investor holds a promise, not stock, and you get capital to build without taking on debt or giving up a board seat.
Three features separate SAFEs from debt instruments: no interest, no maturity date and no repayment obligation. A SAFE is a promise of future equity, not a loan. Conversion triggers generally include a priced equity round and may also include an acquisition, initial public offering (IPO) or dissolution. A priced financing usually triggers conversion rather than a minimum fundraising threshold.
Understanding key terms such as valuation cap, discount, most favored nation (MFN) and pro rata rights will help you feel more confident and prepared, avoiding surprises during your funding process.
The valuation cap is the maximum effective valuation at which an investor's SAFE converts to equity. For a post-money SAFE, divide the investment amount by the post-money valuation cap to get the investor's ownership percentage. An investor who puts in $200K on a $4M post-money cap owns exactly five percent of your company at signing. When your Series A lands above the cap, the SAFE investor still converts at the cap and gets more shares per dollar than new investors.
A discount rate gives SAFE investors a percentage reduction on the per-share price compared to new investors at your priced round. If Series A shares cost $1.00 each, a SAFE with a 20 percent discount converts at $0.80 per share, giving the early investor 25 percent more shares for the same money. When a SAFE includes both a cap and a discount, the investor gets the lower conversion price.
An MFN clause automatically upgrades an early investor's SAFE terms to match the most favorable terms you offer to any later SAFE investor before your priced round. When you later raise SAFEs at a lower cap, that MFN SAFE picks up the better terms. The tradeoff is reduced flexibility in later SAFE negotiations, because one concession can affect MFN holders.
Pro-rata rights give a SAFE holder the option, not the obligation, to invest additional money in your next round to maintain their ownership percentage. These rights can consume allocation that would otherwise go to your Series A lead investor, who often wants meaningful ownership. Granting pro-rata rights to many SAFE holders can complicate your Series A fundraising. Limiting these rights to your largest check-writers and restricting them to the next round only is a common safeguard.
SAFE templates are widely used in startup financings. Roughly 72 percent of SAFEs issued in 2025 used a valuation cap with no discount, making it the dominant structure by a wide margin.
The main differences come down to whether the SAFE includes a cap, a discount or MFN protection. Here are the four types and when each makes sense:
The simpler the structure, the easier it is to model dilution and keep future fundraising clean. Post-money SAFEs became the market standard after the 2018 introduction of the post-money form. Under the older pre-money structure, SAFE investors diluted each other and founders could not calculate their actual ownership until the priced round. The post-money version changed that: every new SAFE dollar dilutes founders, not other SAFE holders, and you can calculate the effect at signing.
A SAFE and a convertible note both delay the valuation conversation, but they are structurally different instruments. A SAFE is equity. A convertible note is debt. That difference changes interest accrual, maturity timing, repayment risk and balance sheet treatment.
Convertible notes typically accrue interest, which means your cap table dilutes as the note remains outstanding. SAFEs convert at the invested amount. Convertible notes also carry maturity dates, which can pressure founders to raise on weak terms or negotiate an extension if no priced round is in sight. SAFEs remove that deadline pressure.
Convertible notes still fit some situations, especially cross-border financings and later-stage bridge rounds where investors want creditor protections. Most pre-seed and seed raises now default to SAFEs.
Stacking multiple SAFEs at different valuation caps is the most common way founders give away more of their company than they intended. Each SAFE locks in a fixed ownership percentage at signing, but all of them convert at the same moment during your Series A. Many founders only discover the total dilution when their lead investor runs the cap table math.
CRV is an early stage venture capital firm, and the companies CRV backs include DoorDash, Mercury and Vercel. CRV led DoorDash's first financing round, so our team is used to working with founders when companies are just a few weeks old..
Founding team ownership often drops sharply by Series A, and SAFE conversions can play a major role in that decline. The over-cap dilution trap hits hardest when your Series A valuation comes in above your highest SAFE cap. Modeling dilution before each SAFE signing is the best defense.
SAFEs fit pre-seed and seed fundraising, where speed and simplicity outweigh the need for formal governance structures. At these stages, you negotiate a small set of variables, usually amount and valuation cap, instead of the full set of terms in a priced round. Closing can happen quickly rather than over weeks. SAFEs dominate the earliest stages of venture fundraising.
Founders usually move to priced equity at Series A and beyond. The Series A is often the first priced round your company raises, in which investors place a formal valuation, determine a share price, and issue preferred stock. Institutional Series A investors generally expect governance structures, board representation and protective provisions that SAFEs do not provide.
This is also when all outstanding SAFEs convert into actual shares, so the Series A is where your early fundraising decisions become visible on the cap table. Bridge rounds remain a viable use case for SAFEs at later stages. In choppy markets, more founders use SAFEs to extend runway while delaying a priced round amid volatile valuations.
The YC SAFE template is the standard document for early stage fundraising, and the default approach is to use it without modification. Deviating from the template adds legal complexity, slows closing and raises questions for investors who expect standard terms. Standardization is a feature.
Your negotiation should focus on two variables: the dollar amount and the valuation cap or discount rate. Everything else in the template usually works as written. Execution can move fast with standard documents, and wires can follow shortly after.
A SAFE does not require legal review to be valid. Most startup attorneys know the YC form well, which helps keep legal bills down. Legal review is most useful when you want help understanding long-term dilution and checking any side letter provisions.
Sophisticated investors compare your proposed valuation cap against real market benchmarks. In 2025, market benchmarks varied meaningfully by round size: lower caps were more common in smaller rounds and higher caps were more common as round size increased. A cap that sits well above market norms without a strong reason, such as traction, competitive pressure or an exceptional team, signals weak pricing discipline to many investors.
Your ability to model your own cap table is a credibility signal that experienced investors notice immediately. If you cannot explain how your existing SAFEs will convert and what ownership will look like after Series A, investors may question your financial judgment and the quality of advice you're getting. We've seen this dynamic play out across decades of early stage investing at CRV: founders who understand their dilution math before a raise usually negotiate better outcomes and build stronger investor relationships.
Side letters are where much of the real negotiation happens in a SAFE round. The base template is standardized, and institutional pre-seed investors increasingly ask for a small set of add-ons.
These are the terms worth watching most closely:
These side letter terms can shape governance long after the SAFE is signed. Knowing which asks are routine and which ones can constrain your next round helps you negotiate with more precision.
A SAFE agreement is the fastest, most founder-friendly way to raise early capital, but its simplicity at signing can hide real dilution consequences down the road. The core skill is not filling out the template. It is modeling your cap table across a range of outcomes before each new SAFE, understanding how all your SAFEs interact at conversion and keeping your total pre-Series A dilution in check so you enter your priced round from a position of strength.
If you're an early stage founder looking for a partner who leads with conviction and provides hands-on support, reach out to us to see if we'd be a good fit.
SAFE stands for Simple Agreement for Future Equity. It lets you raise money now and issue equity later when a triggering event, usually a priced financing, sets the share price.
No. A SAFE is an equity instrument, while a convertible note is a debt instrument. Notes usually include interest and a maturity date, while SAFEs generally do not.
A SAFE does not legally require a lawyer to be valid. Many founders still ask counsel to review the document, especially for a first financing or any side letter terms.
SAFEs usually fit pre-seed and seed stages, not the Series A itself. Series A investors usually want a priced round with preferred stock, governance rights and board terms that a SAFE does not provide.